chitosan has been researched along with Koch's Disease in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 10 (47.62) | 24.3611 |
| 2020's | 9 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Amini, Y; Ayati, SH; Kabiri, M; Mohammadpour, F; Najafi, A; Nikpoor, AR; Tafaghodi, M; Zare, S | 1 |
| Narasimman, V; Rajesh, P; Ramachandran, S | 1 |
| Boni, FI; Chorilli, M; Gremião, MPD; Turco, BO | 1 |
| Abdolalizadeh, J; Amini, Y; Azizian, K; Baradaran, B; Gholizadeh, P; Hasani, A; Hoseinpur, R; Memar, MY; Salehi, R; Samadi Kafil, H | 1 |
| Barbugli, PA; Carnero Canales, CS; Caruso, IP; Chorilli, M; Colturato, VMM; da Silva Barud, H; de Lourenço, IO; de Melo, FA; Franzyk, H; Hansen, PR; Pavan, FR; Primo, LMDG; Roque-Borda, CA; Sábio, RM; Vicente, EF | 1 |
| Ambrus, R; Benke, E; Burián, K; Csóka, I; Farkas, Á; Kókai, D; Mukhtar, M; Pallagi, E; Zeeshan, M | 1 |
| Chavda, J; Ghetiya, R; Shah, S; Soniwala, M | 1 |
| Chaves, LL; Ferreira, D; Lima, SC; Neto, PJR; Pinheiro, M; Reis, S; Sarmento, B; Vieira, ACC | 1 |
| Amini, Y; Ghazvini, K; Gholami, L; Khademi, F; Najafi, A; Sankian, M; Tafaghodi, M; Zare, S | 1 |
| Abdul Gawad, E; Althani, A; Azzazy, HM; Khalil, MA; Tammam, SN; Zaghloul, H | 1 |
| Chan, LW; Shah, K; Wong, TW | 1 |
| Chaves, LL; Ferreira, D; Lima, SC; Pinheiro, M; Pinheiro, S; Pinto, S; Reis, S; Sarmento, B; Vieira, ACC | 1 |
| Khademi, F; Momtazi-Borojeni, AA; Soleimanpour, S; Taheri, RA; Vaez, H; Yousefi Avarvand, A | 1 |
| Priyanka, K; Raghav, R; Rishi, P; Sharma, R; Sharma, S; Srivastava, S; Verma, I | 1 |
| Feng, G; Jiang, Q; Lu, L; Lu, Y; Peng, G; Qiu, W; Wang, Y; Xia, M; Zhao, D | 1 |
| Dube, A; Law, WC; Maponga, CC; Morse, GD; Prasad, PN; Reynolds, JL | 1 |
| Iwamoto, M; Malhotra, BD; Manaka, T; Mukherjee, MD; Solanki, PR; Sumana, G | 1 |
| Ahmad, MI; Nakpheng, T; Srichana, T | 1 |
| Garg, T; Goyal, AK; Gupta, P; Gupta, UD; Rath, G | 1 |
| Franzblau, S; Lu, E; Onyuksel, H; Popescu, C | 1 |
| Khuller, GK; Pandey, R | 1 |
1 review(s) available for chitosan and Koch's Disease
| Article | Year |
|---|---|
Are chitosan natural polymers suitable as adjuvant/delivery system for anti-tuberculosis vaccines?
Topics: Adjuvants, Pharmaceutic; Animals; Antigen-Presenting Cells; Antigens, Bacterial; BCG Vaccine; Chitosan; Drug Delivery Systems; Humans; Immunity, Cellular; Immunization; Polymers; Tuberculosis; Tuberculosis Vaccines; Vaccine Potency | 2018 |
20 other study(ies) available for chitosan and Koch's Disease
| Article | Year |
|---|---|
Immunological Assessment of Chitosan or Trimethyl Chitosan-Coated PLGA Nanospheres Containing Fusion Antigen as the Novel Vaccine Candidates Against Tuberculosis.
Topics: Administration, Intranasal; Animals; Chitosan; Mice; Nanospheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tuberculosis; Vaccines, Subunit | 2021 |
Low molecular weight sulfated chitosan isolation, characterization and anti-tuberculosis activity derived from Sepioteuthis lessoniana.
Topics: Animals; Antitubercular Agents; Chitosan; Decapodiformes; Molecular Weight; Spectroscopy, Fourier Transform Infrared; Sulfates; Tuberculosis | 2022 |
Nanostructured polyelectrolyte complexes based on chitosan and sodium alginate containing rifampicin for the potential treatment of tuberculosis.
Topics: Alginates; Chitosan; Drug Carriers; Humans; Polyelectrolytes; Polymers; Rifampin; Tuberculosis | 2021 |
Chitosan nanoparticles containing fusion protein (Hspx-PPE44-EsxV) and resiquimod adjuvant (HPERC) as a novel booster vaccine for
Topics: Adjuvants, Immunologic; Animals; Antigens, Bacterial; Bacterial Proteins; BCG Vaccine; Chitosan; Escherichia coli; Imidazoles; Immunoglobulin G; Interleukin-17; Interleukin-4; Mice; Mycobacterium tuberculosis; Nanoparticles; Tuberculosis | 2022 |
Antimicrobial peptides grafted onto the surface of N-acetylcysteine-chitosan nanoparticles can revitalize drugs against clinical isolates of Mycobacterium tuberculosis.
Topics: Acetylcysteine; Antimicrobial Peptides; Antitubercular Agents; Chitosan; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nanoparticles; Tuberculosis | 2024 |
Aerodynamic properties and in silico deposition of isoniazid loaded chitosan/thiolated chitosan and hyaluronic acid hybrid nanoplex DPIs as a potential TB treatment.
Topics: Biopolymers; Chitosan; Drug Carriers; Dry Powder Inhalers; Humans; Hyaluronic Acid; Isoniazid; Nanoparticles; Nanostructures; Tuberculosis | 2020 |
Development and Optimization of Inhalable Levofloxacin Nanoparticles for The Treatment of Tuberculosis.
Topics: Chitosan; Drug Carriers; Drug Liberation; Humans; Levofloxacin; Nanoparticles; Particle Size; Tuberculosis | 2021 |
Lipid nanoparticles coated with chitosan using a one-step association method to target rifampicin to alveolar macrophages.
Topics: A549 Cells; Antibiotics, Antitubercular; Chitosan; Drug Carriers; Drug Liberation; Humans; Lipids; Macrophages, Alveolar; Nanoparticles; Particle Size; Rifampin; Tuberculosis | 2021 |
T helper type 1 biased immune responses by PPE17 loaded core-shell alginate-chitosan nanoparticles after subcutaneous and intranasal administration.
Topics: Administration, Intranasal; Alginates; Animals; Antigens, Bacterial; Chitosan; Drug Carriers; Injections, Subcutaneous; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Th1 Cells; Tuberculosis; Tuberculosis Vaccines | 2021 |
Chitosan gold nanoparticles for detection of amplified nucleic acids isolated from sputum.
Topics: Chitosan; DNA, Bacterial; Gold; Humans; Metal Nanoparticles; Mycobacterium tuberculosis; Sensitivity and Specificity; Sputum; Tuberculosis | 2017 |
Critical physicochemical and biological attributes of nanoemulsions for pulmonary delivery of rifampicin by nebulization technique in tuberculosis treatment.
Topics: Administration, Inhalation; Antitubercular Agents; Cell Line; Chemistry, Pharmaceutical; Chitosan; Drug Liberation; Emulsions; Macrophages; Nanoparticles; Oleic Acid; Particle Size; Rifampin; Tuberculosis; Viscosity | 2017 |
Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis.
Topics: Antitubercular Agents; Chitosan; Drug Carriers; Drug Liberation; Excipients; Lipids; Nanoparticles; Nanostructures; Particle Size; Rifampin; Tuberculosis | 2018 |
Exploiting chitosan and gold nanoparticles for antimycobacterial activity of in silico identified antimicrobial motif of human neutrophil peptide-1.
Topics: alpha-Defensins; Antitubercular Agents; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Discovery; Gold; Humans; Metal Nanoparticles; Mycobacterium tuberculosis; Tuberculosis | 2019 |
Enhanced immune response and protective effects of nano-chitosan-based DNA vaccine encoding T cell epitopes of Esat-6 and FL against Mycobacterium tuberculosis infection.
Topics: Amino Acid Sequence; Animals; Antigens, Bacterial; Bacterial Proteins; Cell Count; Cell Proliferation; Chitosan; Cytokines; Epitopes, T-Lymphocyte; Female; fms-Like Tyrosine Kinase 3; GATA3 Transcription Factor; Gene Expression Regulation; Immunization; Interferon-gamma; Ligands; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Mycobacterium tuberculosis; Nanoparticles; Particle Size; Recombinant Proteins; Spleen; T-Box Domain Proteins; T-Lymphocytes, Cytotoxic; Transfection; Tuberculosis; Vaccines, DNA | 2013 |
Multimodal nanoparticles that provide immunomodulation and intracellular drug delivery for infectious diseases.
Topics: Chitosan; Cytokines; Drug Delivery Systems; Female; Humans; Immunologic Factors; Lactic Acid; Male; Monocytes; Mycobacterium tuberculosis; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tuberculosis | 2014 |
Thiol modified chitosan self-assembled monolayer platform for nucleic acid biosensor.
Topics: Biosensing Techniques; Chitosan; DNA; Gold; Humans; Mycobacterium tuberculosis; Spectroscopy, Fourier Transform Infrared; Thioglycolates; Tuberculosis | 2014 |
The safety of ethambutol dihydrochloride dry powder formulations containing chitosan for the possibility of treating lung tuberculosis.
Topics: Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Ethambutol; Humans; Lung; Nanoparticles; Particle Size; Powders; Tuberculosis | 2014 |
Chemotherapeutic Evaluation of Guar Gum Coated Chitosan Nanoparticle Against Experimental Tuberculosis.
Topics: Animals; Antitubercular Agents; Chitosan; Coated Materials, Biocompatible; Delayed-Action Preparations; Diffusion; Female; Galactans; Isoniazid; Mannans; Mice; Mice, Inbred BALB C; Nanocapsules; Plant Gums; Rifampin; Treatment Outcome; Tuberculosis | 2016 |
Preparation of aminoglycoside-loaded chitosan nanoparticles using dextran sulphate as a counterion.
Topics: Administration, Oral; Aminoglycosides; Animals; Anti-Bacterial Agents; Chitosan; Dextran Sulfate; Gentamicins; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nanoparticles; Streptomycin; Tobramycin; Tuberculosis | 2009 |
Chemotherapeutic potential of alginate-chitosan microspheres as anti-tubercular drug carriers.
Topics: Alginates; Animals; Antitubercular Agents; Chitin; Chitosan; Drug Carriers; Female; Glucuronic Acid; Guinea Pigs; Hexuronic Acids; Male; Microspheres; Tissue Distribution; Tuberculosis | 2004 |